Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects

NCT03005041 | Completed Results

• 1 other identifier: 205067
• Study Type: interventional
• Target: 56
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to investigate the consumer perception of an experimental mouthwash formulation in population with dry mouth

Conditions

Xerostomia

Outcome Measures

Primary Outcomes (1)

• Number of Participants With Response to Post-Product Use Questionnaires 1 (PPUQ 1); Question No.1

  Participants answered the following question, Q1: how much do you agree or disagree with the following statements about this product, having used it? "This product is gentle": disagree strongly, disagree, neither agree nor disagree, agree, or agree strongly. There was no formal statistical hypothesis to be tested for this outcome..

  Within 2 minutes post product use

Secondary Outcomes (3)

• Number of Participants With Response to Post-Product Use Questionnaires 1 (PPUQ 1); Question No. 3-7

  Within 2 minutes post product use

• Number of Participants With Response to Post-Product Use Questionnaires 2 (PPUQ 2)

  Within 30 ± 5 minutes post product use

• Number of Participants With Response to Product Performance Attribute Questionnaire (PPAQ)

  Within 5 minutes post product use

Study Arms (2)

Test Product 1

EXPERIMENTAL

Participants will rinse their mouth with 15 mL of the product swishing for 30 seconds.

Other: Biotene mouthwash

Test Product 2

OTHER

Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds. Participants then spit out the water.

Other: Bottled mineral water

Interventions

Biotene mouthwash OTHER

Participants will rinse their mouth with 15 mL of Biotene mouthwash swishing for 30 seconds.

Test Product 1

Bottled mineral water OTHER

Participants will rinse their mouth with 15 mL of the water swishing for 30 seconds.

Test Product 2

Eligibility Criteria

• Age: 18 Years - 84 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form
• Aged 18 - 84 years inclusive
• Good general and mental health with, in the opinion of the investigator or medically qualified designee no clinically significant and relevant abnormalities in medical history or upon oral examination
• Participant reports having a feeling of a dry mouth according to the Dry Mouth Screening Questionnaire (DMSQ) (Subject must answer at least 2 out of the 4 questions with 'agree a little', 'agree' or 'strongly agree' at the Screening Visit (Visit 1). Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min at the Screening Visit (Visit 1).
• Participants with un-stimulated whole salivary flow rate of ≤0.1 ml/min ATH the Screening Visit (Visit 1).
• Understands and is willing, able and likely to comply with all study procedures and restrictions

You may not qualify if:

• Women who are known to be pregnant or who are intending to become pregnant over the duration of the study or have a positive urine pregnancy test at the Screening Visit
• Women who are breast-feeding
• Participant is currently undergoing radiotherapy and/or chemotherapy treatment
• Any condition the investigator identifies that can confound the participant's ability to properly participate in the study e.g. Alzheimer's Disease
• Participant with untreated oral mucosal disease which in the opinion of the investigator could interfere with the study (e.g. current oral ulceration)
• Evidence of gross intra-oral neglect or need for extensive dental therapy
• Denture wearer (complete dentures)
• Participant not on stable doses of prescription systemic parasympathetic medications (e.g. Pilocarpine), for the treatment of the feeling of dry mouth
• Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients
• Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 14 days of the screening visit
• Previous participation in this study
• Recent history (within the last 1 year) of alcohol or other substance abuse
• An employee of the sponsor or the clinical study team or members of their immediate family. Students and employees of the Tufts University School of Dental Medicine not associated with the clinical trials team are eligible to participate. Students and employees will not be specifically targeted for enrollment
• Non-English speaking Participants will not be enrolled in the study. Participants must be able to read and write in English

Sponsors & Collaborators

• GlaxoSmithKline: lead

Study Sites (1)

GSK Investigational Site

Boston, Massachusetts, 02111, United States

Location

MeSH Terms

Conditions

Xerostomia

Condition Hierarchy (Ancestors)

Salivary Gland Diseases; Mouth Diseases; Stomatognathic Diseases

Results Point of Contact

• Title: GSK Response Center
• Organization: GlaxoSmithKline

866-435-7343

Study Officials

• GSK Clinical Trials

  GlaxoSmithKline

  STUDY DIRECTOR

Publication Agreements

• PI is Sponsor Employee: No
• Restriction Type: OTHER
• Restrictive Agreement: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: OTHER
• Intervention Model: CROSSOVER
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 30, 2016
• First Posted: December 29, 2016
• Study Start: August 31, 2016
• Primary Completion: October 19, 2016
• Study Completion: October 19, 2016
• Last Updated: July 19, 2018
• Results First Posted: April 3, 2018

Record last verified: 2017-08

Locations

US (1)